Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 76.16M P/E - EPS this Y 1.40% Ern Qtrly Grth -
Income -31.05M Forward P/E -3.00 EPS next Y 31.90% 50D Avg Chg -33.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -40.00%
Dividend N/A Price/Book 3.33 EPS next 5Y - 52W High Chg -72.00%
Recommedations 2.00 Quick Ratio 0.67 Shares Outstanding 53.98M 52W Low Chg 6.00%
Insider Own 3.20% ROA -51.71% Shares Float 48.49M Beta 1.17
Inst Own 12.49% ROE -158.25% Shares Shorted/Prior 6.81M/6.97M Price 1.53
Gross Margin - Profit Margin - Avg. Volume 277,291 Target Price 8.47
Oper. Margin - Earnings Date May 10 Volume 526,513 Change -6.13%
About Cel-Sci Corporation

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical trials for the potential treatment of certain head and neck cancers. It is also developing products based on its proprietary technology Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer. In addition, the company's product pipeline includes CEL-2000; CEL-4000; and CEL-5000, which are LEAPS-based product candidates in preclinical trials for the treatment of rheumatoid arthritis disease. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.

Cel-Sci Corporation News
04/23/24 CEL-SCI Appoints Mario Gobbo to Its Board of Directors
04/15/24 CVM: Parallel Engagement on Four Fronts
03/19/24 CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
03/06/24 CEL-SCI Corporation Issues Letter to Shareholders
02/15/24 CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results
02/13/24 CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock
02/09/24 CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
02/06/24 CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug
01/31/24 European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®
01/08/24 CVM: Fiscal Year 2023 in Review
12/22/23 CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments
12/08/23 CVM: NICE To Have Your Support
12/04/23 UK’S National Institute for Health and Care Excellence (NICE) Selects CEL-SCI’s Multikine as Potential New Standard of Care for Head & Neck Cancer
11/20/23 CEL-SCI Announces Closing of $5 Million Public Offering of Common Stock
11/16/23 CEL-SCI Announces Pricing of $5 Million Offering of Common Stock
11/09/23 12 Best Day Trading Stocks To Buy
11/08/23 CVM: Target Population Comes Into Relief
10/30/23 CEL-SCI Issues Letter to Shareholders
10/24/23 CEL-SCI Releases Video Detailing Recent Phase 3 Findings & its Plans to Seek Immediate Regulatory Approvals
10/23/23 5-Year Head & Neck Cancer Survival Increased From 45% to 73% in CEL-SCI’s Target Population, Cutting Risk of Death in Half, as Presented at Leading Cancer Conference ESMO 2023
CVM Chatroom

User Image LaurenBiotech Posted - 9 hours ago

$CVM From the 1979 movie The Jerk, a lesson many here failed to learn: you need to know the difference between sh*t and Shinola. Groot sold y'alls a pile of sh*t.

User Image Johnyd Posted - 19 hours ago

$CVM ...even AGEN IS UP.

User Image Johnyd Posted - 20 hours ago

$CVM you really wonder why the silent act from barty..:what exactly they are waiting on.

User Image Westcoastcrippler Posted - 22 hours ago

$CVM Wow typical libtard move. He blocked me.

User Image Sarah53 Posted - 22 hours ago

$CVM we still believe

User Image BioGLovesMe Posted - 22 hours ago

$CVM So sad to find that @Westcoastcrippler finally blocked me. I guess he got tired of being called out for being absolutely wrong about CVM. Sad magatards. I really want to know why so many of them are CVM "bulls" yet hold such anti-science views. How that work? Either way good riddance. There's no value to those who lob around false accusations like "pedophile."

User Image prophet777 Posted - 1 day ago

$CVM Geert we are all expecting your usual 10% down… please don’t disappoint!!!

User Image Jeff226 Posted - 1 day ago

$CVM

User Image ShortKillerMD Posted - 1 day ago

$CVM Winning! 1. Rs say no foreign aid without border security 2. Ds say nope 3. Rs say then no aid 4. Ds cave, cut a deal for tougher border laws with Lankford and McConnell 5. Trump tells them to kill it 6. Rs kill it 7. Rs pass foreign aid without the border security

User Image Johnyd Posted - 1 day ago

$CVM CVM is closing the doors. SOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOON!

User Image Westcoastcrippler Posted - 1 day ago

$CVM

User Image Johnyd Posted - 1 day ago

$CVM get rid of bert!

User Image Johnyd Posted - 1 day ago

$CVM NO NICE +no FDA=no mk= .25 cent stock They never did go to the EU

User Image giu_ve Posted - 1 day ago

$CVM Gerry, sell already. Going forward being such a small Company is too risky. I know you would like to get your good salary till your pension, however it is time to think seriously about shareholders for once. Even 800 mlns is good enough. If not possible try between 350 to 400 mlns. Please, thanks

User Image NoBodyUKnow Posted - 1 day ago

$CVM buck and a half, buck and a half, anyone? Buck and a quarter, who will give me a buck and a quarter?

User Image G101SPM Posted - 1 day ago

$CVM $1.45 bid. ... BUY 2X/ADD TO LONG POSITION. DAC (7) [as in 7 trades) $1.80. EXIT $3.00 (First level carries SPM 81.76 tag in the midterm.)

User Image BooBoo1868 Posted - 1 day ago

$CVM The year is 2032 1st interaction with alien life. Musk does the first man mission to Mars. CVM is still working on their paperwork. News should be anyday now.

User Image prophet777 Posted - 1 day ago

$CVM down to a $1 we go… next stop $.5… Geert you doing amazing… did you shorted your own company?

User Image ShortKillerMD Posted - 1 day ago

$CVM Can’t wait for May 1 to see how Fanni kicks that can down the road. Freak is delusional expecting a bo by then Laughing and laughing at $1.45 Cheers

User Image Johnyd Posted - 1 day ago

$CVM where the English? have they betrayed you?

User Image GodBlessGold Posted - 1 day ago

$CVM damn we broke the 1.50

User Image Johnyd Posted - 1 day ago

$CVM '...... 45 days..............................." declara's children posted!

User Image Westcoastcrippler Posted - 1 day ago

$CVM https://www.businesswire.com/news/home/20240423365855/en/CEL-SCI-Appoints-Mario-Gobbo-to-Its-Board-of-Directors

User Image Westcoastcrippler Posted - 2 days ago

$CVM

User Image G101SPM Posted - 2 days ago

$CVM $1.50. DAC (6) $1.74 last $1.58 (4.11.24). CHANGE EXIT TO $5.00 FROM $3.00. NEWS: Announced the appointment of Mario Gobbo to its Board of Directors. “Mr. Gobbo has a unique background where science and Wall Street interact to create new medicines. He has backed many successful healthcare ventures and he has excellent contacts in that part of finance that is interested in building medical breakthroughs into great companies. We are honored to receive his help in bringing Multikine to market as a treatment for head and neck cancer,” stated CEL-SCI(CVM) CEO Geert Kersten. Mr. Gobbo commented, “This is an exciting and extremely important moment to join the board of CEL-SCI(CVM) as it is on the brink of developing a product that will revolutionize certain head and neck cancer therapies and probably other deadly cancers. I am proud and honored to become part of the CEL-SCI(CVM) team.”

User Image 70GS455 Posted - 2 days ago

$CVM

User Image Jeff226 Posted - 2 days ago

$CVM

User Image FanniWinningLikeFishboy Posted - 2 days ago

$CVM 7 days left in April. You really think they haven’t had at least one meeting yet? So why wait to share the news? Bad feedback? Good feedback? My opinion is it’s likely that the partner or buyer was contingent on the feedback and they’re finalizing a deal. Or it’ll be another lame duck.

User Image Johnyd Posted - 2 days ago

$CVM NOBODY is going to make any more MK. No money left to bring the FDA to the "facilitee". Git Carsteen is lying na gid shinty faced boom.

User Image Basman Posted - 2 days ago

$CVM bullish as hell…! Great stock, we will be rich soon.

Analyst Ratings
EF Hutton Buy Jul 12, 23
EF Hutton Buy Mar 9, 23
EF Hutton Buy Dec 29, 22
EF Hutton Buy Apr 7, 22
HC Wainwright & Co. Buy Jan 13, 20
Taglich Brothers Speculative Buy Feb 20, 13
Chardan Capital Buy Feb 13, 13
Laidlaw & Co. Buy Jan 14, 13